Table 1.
Treatment | TIME (days) | ||||||
---|---|---|---|---|---|---|---|
Day 0 | Day 1 | Day 1.5 | Day 2 | Day 2.5 | Day 3 | Day 3.5 | |
Control | 72.32 ± 7.32 | 47.02 ± 4.84 | 33.28 ± 3.06 | 12.93 ± 3.36 | 6.12 ± 3.24 | 0.53 ± 0.99 | 0.06 ± 0.16 |
s-PRGF | 71.91 ± 4.39 | 46.19 ± 4.06 | 30.22 ± 4.09 | 10.00 ± 3.15 | 3.65 ± 2.79 | 0.05 ± 0.10 | 0 |
NaHA | 72.48 ± 5.13 | 45.32 ± 4.20 | 36.72 ± 7.74 | 12.46 ± 5.17 | 5.98 ± 3.69 | 0.65 ± 1.23 | 0.10 ± 0.27 |
s-PRGF + NaHA | 72.57 ± 2.77 | 48.06 ± 8.97 | 37.44 ± 7.63 | 13.59 ± 5.26 | 6.14 ± 3.71 | 0.46 ± 0.76 | 0.02 ± 0.06 |
No significant differences between any treatments were found (Kruskal–Wallis test, p ≥ 0.05).